SK287348B6 - Monoklonálne protilátky proti ľudskému LDL receptoru, spôsob ich prípravy a ich použitie - Google Patents

Monoklonálne protilátky proti ľudskému LDL receptoru, spôsob ich prípravy a ich použitie Download PDF

Info

Publication number
SK287348B6
SK287348B6 SK1312-2002A SK13122002A SK287348B6 SK 287348 B6 SK287348 B6 SK 287348B6 SK 13122002 A SK13122002 A SK 13122002A SK 287348 B6 SK287348 B6 SK 287348B6
Authority
SK
Slovakia
Prior art keywords
monoclonal antibody
antibody
deposited
ldlr
under number
Prior art date
Application number
SK1312-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK13122002A3 (sk
Inventor
Nachum Yonah
Dany Suissa
Ilana Belzer
Francesco Antonetti
Moshe Smolarsky
Michel Dreano
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287348(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of SK13122002A3 publication Critical patent/SK13122002A3/sk
Publication of SK287348B6 publication Critical patent/SK287348B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1312-2002A 2000-03-13 2001-03-08 Monoklonálne protilátky proti ľudskému LDL receptoru, spôsob ich prípravy a ich použitie SK287348B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (2)

Publication Number Publication Date
SK13122002A3 SK13122002A3 (sk) 2003-04-01
SK287348B6 true SK287348B6 (sk) 2010-08-09

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1312-2002A SK287348B6 (sk) 2000-03-13 2001-03-08 Monoklonálne protilátky proti ľudskému LDL receptoru, spôsob ich prípravy a ich použitie

Country Status (33)

Country Link
US (1) US6849720B2 (ru)
EP (1) EP1263790B1 (ru)
JP (1) JP4768193B2 (ru)
KR (1) KR100882081B1 (ru)
CN (1) CN1418225B (ru)
AR (1) AR028518A1 (ru)
AT (1) ATE362490T1 (ru)
AU (2) AU4100201A (ru)
BG (1) BG65762B1 (ru)
BR (1) BR0109164A (ru)
CA (1) CA2402593C (ru)
CY (1) CY1108020T1 (ru)
CZ (1) CZ20023098A3 (ru)
DE (1) DE60128452T2 (ru)
DK (1) DK1263790T3 (ru)
EA (1) EA007494B1 (ru)
EE (1) EE200200517A (ru)
ES (1) ES2282238T3 (ru)
HK (1) HK1055750A1 (ru)
HR (1) HRP20020704B1 (ru)
HU (1) HU226194B1 (ru)
IL (2) IL139217A0 (ru)
MX (1) MXPA02009091A (ru)
NO (1) NO330904B1 (ru)
NZ (1) NZ520944A (ru)
PL (1) PL206041B1 (ru)
PT (1) PT1263790E (ru)
RS (1) RS51406B (ru)
SI (1) SI1263790T1 (ru)
SK (1) SK287348B6 (ru)
UA (1) UA78489C2 (ru)
WO (1) WO2001068710A1 (ru)
ZA (1) ZA200206654B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
CA2525517C (en) 2003-06-19 2016-05-31 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
US20090305258A1 (en) * 2006-02-17 2009-12-10 Paolo La Colla Methods for the diagnosis of proliferative and/or conformational diseases
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
CN103429265A (zh) 2010-05-25 2013-12-04 国家医疗保健研究所 用于治疗和预防hcv感染的抗包膜抗体和抗受体抗体组合物
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
BG107063A (bg) 2003-05-30
CN1418225A (zh) 2003-05-14
HU226194B1 (hu) 2008-06-30
BR0109164A (pt) 2002-11-26
CZ20023098A3 (cs) 2003-02-12
HRP20020704A2 (en) 2004-12-31
PL358381A1 (en) 2004-08-09
BG65762B1 (bg) 2009-10-30
NO330904B1 (no) 2011-08-15
EA200200974A1 (ru) 2003-02-27
ATE362490T1 (de) 2007-06-15
DE60128452T2 (de) 2007-09-13
NZ520944A (en) 2004-04-30
US6849720B2 (en) 2005-02-01
WO2001068710A1 (en) 2001-09-20
KR20020089384A (ko) 2002-11-29
SI1263790T1 (sl) 2007-10-31
YU68602A (sh) 2006-03-03
US20030186343A1 (en) 2003-10-02
HK1055750A1 (en) 2004-01-21
ZA200206654B (en) 2003-10-20
UA78489C2 (en) 2007-04-10
CY1108020T1 (el) 2013-09-04
CA2402593A1 (en) 2001-09-20
MXPA02009091A (es) 2005-06-20
HUP0300142A3 (en) 2005-07-28
NO20024223L (no) 2002-10-24
PL206041B1 (pl) 2010-06-30
HRP20020704B1 (en) 2011-01-31
DE60128452D1 (de) 2007-06-28
EA007494B1 (ru) 2006-10-27
EP1263790B1 (en) 2007-05-16
DK1263790T3 (da) 2007-07-02
IL139217A0 (en) 2001-11-25
AU4100201A (en) 2001-09-24
RS51406B (sr) 2011-02-28
AU2001241002B8 (en) 2006-05-04
EE200200517A (et) 2004-02-16
IL151713A0 (en) 2003-04-10
AR028518A1 (es) 2003-05-14
CA2402593C (en) 2012-07-03
JP4768193B2 (ja) 2011-09-07
ES2282238T3 (es) 2007-10-16
AU2001241002B2 (en) 2006-04-06
HUP0300142A2 (hu) 2003-06-28
KR100882081B1 (ko) 2009-02-10
PT1263790E (pt) 2007-06-01
CN1418225B (zh) 2012-04-18
JP2004506603A (ja) 2004-03-04
EP1263790A1 (en) 2002-12-11
SK13122002A3 (sk) 2003-04-01
NO20024223D0 (no) 2002-09-04

Similar Documents

Publication Publication Date Title
US6849720B2 (en) Monoclonal antibodies to the human LDL receptor, their production and use
JPH06506120A (ja) ヒト腫瘍壊死因子に特異的なモノクローナルなキメラ抗体
US4816249A (en) Monoclonal anti-idiotype antibodies
JPH02154696A (ja) 新規キメラ抗体
CZ292295B6 (cs) Rekombinantní protilátková molekula, DNA sekvence, terapeutická nebo diagnostická kompozice a použití protilátkové molekuly
US6316600B1 (en) Methods for the production of chicken monoclonial antibodies
AU2001241002A1 (en) Monoclonal antibodies to the human LDL receptor, their production and use
US9382316B2 (en) Humanized anti-EMAP II antibody and use thereof
EP0396505A2 (en) Monoclonal antibodies specific for an immunoglobulin isotype
EP0168907B1 (en) Monoclonal antibodies recognizing l-thyroxine
MXPA06003886A (es) Reactivos de enlace de inmunoglobulina naturales y metodos de fabricacion y uso de los mismos.
JPS6115897A (ja) ヒト肝癌細胞を特異的に認識するモノクロ−ナル抗体
JPH05276988A (ja) 新規抗ｈｉｖ抗体
USRE39548E1 (en) Interleukin-5 specific recombinant antibodies
AU2004236263A1 (en) Compositions and methods for treatment of cryptococcosis
JPH1121300A (ja) 抗ヒトトランスフェリンモノクローナル抗体及びこれを産生するハイブリドーマ細胞株

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SERONO SA, COINSINS, VAUD, CH

Effective date: 20120709

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160308